Genomictree Market Cap

Genomictree has a market cap or net worth of 331.48 billion as of May 20, 2026. Its market cap has decreased by -6.64% in one year.

Market Cap

331.48B

Enterprise Value

256.72B

Revenue

3.76B

Ranking

n/a

PE Ratio

n/a

Stock Price

13,900.00

Market Cap Chart

Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 331.48B, an increase of 461.84%. That is a compound annual growth rate of 20.81%.

Market Cap History

Date	Market Cap	% Change
May 20, 2026	331.48B	-49.73%
Dec 30, 2025	659.41B	34.41%
Dec 30, 2024	490.60B	0.78%
Dec 28, 2023	486.82B	168.25%
Dec 29, 2022	181.48B	-32.87%
Dec 30, 2021	270.36B	-7.66%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Proteina	484.62B
SillaJen	417.05B
Helixmith	333.38B
Anterogen.Co.,Ltd.	316.69B
GC Cell	315.57B
BINEX	301.60B
HLB Therapeutics	278.15B
NeoImmuneTech	247.66B

Market Cap Rankings